Results

Total Results: 344 records

Showing results for "liver".
Users also searched for: hepatitis c

221. Lysosomal-Storage-Diseases-Therapies Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/lysosomal-storage-diseases-therapies_research-protocol.pdf
     November 15, 2012 - respiratory insufficiency, hearing loss, joint movement restriction, enlargement of the heart, spleen, and liver

222. renal-update-2015-150115 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-update_research-protocol.pdf
     January 15, 2015 - and adverse events of the drugs are well-understood and include symptomatic hypotension, myalgia, liver

223. Evidence-based Practice Center Technical Brief Protocol: Disparities and Barriers for Pediatric Cancer Survivorship Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/pediatric-cancer-survivorship-protocol.pdf
     June 01, 2020 - disease and heart failure, decreased pulmonary function, infertility, hormonal changes, kidney failure, liver

224. 8 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-harms_methods.pdf
     November 01, 2008 - method based on the conclusions of international consensus meetings: application to drug-induced liver … reviews, the term is often used to refer to laboratory-determined abnormalities, such as elevated liver

225. 8 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_chou_assessing_harms_when_comparing.pdf
     November 01, 2008 - method based on the conclusions of international consensus meetings: application to drug-induced liver … reviews, the term is often used to refer to laboratory-determined abnormalities, such as elevated liver

226. Fatty-Acids-Cardiovascular-Disease Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/fatty-acids-cardiovascular-disease_research-protocol.pdf
     April 02, 2015 - (cod liver oil$ or codliver oil$ or marine oil$ or marine fat$).mp. … (cod liver oil$ or codliver oil$ or marine oil$ or marine fat$).mp.

227. Lipid Metabolism Disorders | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/lipid-metabolism-disorders

228. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1506.pdf
     October 01, 2015 - patients treated with nintedanib included abdominal pain, decreased appetite, diarrhea, elevated liver … 62% nintedanib vs. 18% placebo)  Nausea (24% vs. 7%)  Abdominal pain (15% vs. 6%)  Elevated liver … needed is lower than the number of organs needed for other types of transplantation (i.e., kidneys, livers

229. Nonopioid Pharmacologic Treatments for Chronic Pain: Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-summary.pdf
     April 01, 2020 - NSAIDs have increased risk of serious gastrointestinal, liver dysfunction, and cardiovascular adverse … Gastrointestinal events Moderate +/++ No evidence No evidence No evidence Moderate + No evidence Liver

230. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypothyroidism-hyperthyroidism-screening-treatment_research-protocol.pdf
     March 11, 2010 - Liver problems k. Agranulocytosis 2. Radioactive Iodine Treatment: a.

231. Protocol: Imaging for Pretreatment Staging of Small Cell Lung Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/lung-cancer-staging_research-protocol.pdf
     December 08, 2014 - 5% were localized (the other 4% were unstaged).6 The most common sites of metastases for SCLC are liver … proven or suspected SCLC undergo CT of the chest and abdomen, or CT of the chest extending through the liver

232. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/11_pepticulcer_potential_high_impact_june_2012.pdf
     January 01, 2012 - Long-term PN can lead to serious side effects such as liver damage, the risk of which increases the … with SBS is 30%. 40 Long-term parenteral nutrition (PN) can lead to serious side effects such as liver

233. Executive Summary - Nutrition as Prevention for Improved Cancer Outcomes: Comparative Effectiveness Review No. 260 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-260-improved-cancer-outcomes-executive-summary_0.pdf
     May 01, 2023 - A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver

234. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - and children who are at least 12 years old and for treating hepatic encephalopathy in adults with liver … FDA approves new use of Xifaxan for patients with liver disease. [internet].

235. Finding Evidence for Comparing Medical Interventions (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-finding-evidence_methods.pdf
     January 01, 2011 - 2006 Adverse Effects search approach MEDLINE EMBASE specified adverse effects Drug terms AND Exp LIVER … DISEASES/ci Drug terms AND Exp LIVER DISEASE/si subheadings linked to drug name Exp DRUG NAMEadverse

236. Horizon Scanning_Rapid Cost Analyses of Selected Potential High-Impact Intervention Reports (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
     January 01, 2015 - The promise of these drugs is prevention of liver failure, its high treatment costs, and avoidance of … a need for liver transplantation. … achieve acceptable lipid levels and remain at increased risk of having early coronary events, needing liver … After 20 months of treatment, lomitapide would be more costly than the half-million dollar cost of liver

237. Antipsychotics-Children-Surveillance-150120 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children-surveillance-150120.pdf
     October 01, 2014 - neutral weight and metabolic profile8; another that found no clinically significant changes in BMI, liver … similar common adverse events, with no clinically significant changes in movement disorder scales, BMI, liver … RCT and the OLE, no clinically significant mean changes in movement disorder scales, BMI z-scores, liver … common adverse events, with no clinically significant changes in movement disorder scales, BMI, liver

238. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-radiation_technical-brief.pdf
     November 01, 2009 - including sacral tumors, mainly chordomas and chondrosarcomas • Gastrointestinal cancers, including liver … malignancies were also described: gastrointestinal (esophageal cancer, hepatocellular carcinomas of the liver … age Median value Range Ocular 91 58 35-66 Head/neck 50 49 33-66 Spine 9 51 41-66 GI (including liver

239. AHRQ Evidence-Based Practice Center (EPC) Program Research Gaps Summary: Pain Management (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gaps-pain-management.pdf
     January 01, 2023 - NSAIDs have increased risk of serious gastrointestinal, liver dysfunction, and cardiovascular adverse

240. Vitamin D Deficiency | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/vitamin-d-deficiency